companydata.dkcompanydata.dk

LEO PHARMA A/S: Financial statements 2020

CVR: 56759514

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

LEO PHARMA A/S (CVR 56759514) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 10,133,000,000 and a net result of DKK -951,000,000 compared with DKK -1,287,000,000 the year before. That is a decrease of 6.2% compared with the year before. The profit margin was -9.4%. Equity in the 2020 report amounted to DKK 6,947,000,000. The solvency ratio was 29.1%.

Revenue
DKK 10,133,000,000
Gross Profit
DKK 6,773,000,000
Profit/Loss
DKK -951,000,000
Equity
DKK 6,947,000,000
Total Assets
DKK 23,853,000,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202010.1 mia.6.8 mia.-951 mio.6.9 mia.-
201910.8 mia.7.5 mia.-1.3 mia.8.1 mia.-
201810.4 mia.7.4 mia.1.3 mia.9.5 mia.-
201710.5 mia.7.5 mia.1.4 mia.8.3 mia.-
20167.4 mia.2.7 mia.743 mio.25.2 mia.5170

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is LEO PHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Rifat Ramicevic joins the board of LEO PHARMA A/SJul 2, 2020

As of July 2, 2020, Rifat Ramicevic has joined the board of directors of LEO PHARMA A/S.

Laurids Bonne Bjørnshauge leaves the board of LEO PHARMA A/SJul 2, 2020

As of July 2, 2020, Laurids Bonne Bjørnshauge has left the board of directors of LEO PHARMA A/S.

LEO PHARMA A/S: The 2019 annual report is outMar 15, 2020

LEO PHARMA A/S has published its annual report for 2019. Revenue came to DKK 10,805,000,000, and the net result was DKK -1,287,000,000.

Patrik Olof Dahlén leaves the board of LEO PHARMA A/SFeb 25, 2020

As of February 25, 2020, Patrik Olof Dahlén has left the board of directors of LEO PHARMA A/S.

About LEO PHARMA A/S

LEO PHARMA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1962. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB. The management consists of Christophe Dominique Luc Charles Bourdon and Philip Harald Eickhoff. The board consists of Jesper Brandgaard (chair), Paul Olivier Marie Navarre, Peter Helt Jacobsen Haahr and Aino Anna Liisa Hurme. The company is owned by LEO Holding A/S and Cidron Savanna 4 SARL. The company has 1,047 employees (2026). In 2025, the company reported revenue of DKK 13,499,000,000 and a net result of DKK 2,489,000,000 compared with DKK -1,776,000,000 the year before. Equity in the 2025 report amounted to DKK 5,262,000,000.

Source: annual report 2025, Danish Business Authority